Close

CRISPR Therapeutics (CRSP) PT Lowered to $101 at Stifel

Go back to CRISPR Therapeutics (CRSP) PT Lowered to $101 at Stifel

Form 8-K CRISPR Therapeutics AG For: Oct 12

October 12, 2021 4:47 PM EDT

Exhibit 99.1

CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed

or Refractory CD19+ B-cell malignancies

... More